CAR-T 2.0? A split, universal and programmable system – FierceBiotech
FierceBiotech |
CAR–T 2.0? A split, universal and programmable system
FierceBiotech Recent FDA approvals have validated the use of chimeric antigen receptor T cells (CAR-Ts) to fight blood cancers, but the technology is still far from perfect. Researchers working on CAR-T therapies have run into problems with patient relapse, toxicity … Senti scientific co-founder Wilson Wong designs the SUPRA — a new, high performance model CAR–T |
